APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liposomes

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Liposomes Market Analysis and Forecast 2026-2032

20 December 2025193 pages

Choose your research edition.

Industry ResearchLiposomes Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Liposomes Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Liposomes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liposomes Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Liposomes Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Liposomes market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Liposomes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Liposomes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Liposomes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Liposomes is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Liposomes include CSPC, Fudan-Zhangjiang, Gilead Sciences, Kingond Pharm, Luye Pharma, Pacira, Sigma-Tau Group, Spectrum Pharmaceuticals and Teva Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Liposomes, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Liposomes, also provides the sales of main regions and countries. Of the upcoming market potential for Liposomes, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liposomes sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Liposomes market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Liposomes sales, projected growth trends, production technology, application and end-user industry.

Liposomes Segment by Company

CSPC

Fudan-Zhangjiang

Gilead Sciences

Kingond Pharm

Luye Pharma

Pacira

Sigma-Tau Group

Spectrum Pharmaceuticals

Teva Pharmaceutical

Novartis

Johnson & Johnson

Shanghai New Asia

Sun Pharmaceutical

Liposomes Segment by Type

Liposomal Doxorubicin

Liposomal Amphoteracin B

Liposomal Paclitaxel

Others

Liposomes Segment by Application

Fungal Infection Therapy

Cancer & Tumor Therapy

Others

Liposomes Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposomes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liposomes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposomes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Liposomes in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Liposomes manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposomes sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Liposomes Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Liposomal Doxorubicin Major Manufacturers Table 3. Liposomal Amphoteracin B Major Manufacturers Table 4. Liposomal Paclitaxel Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Liposomes Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Fungal Infection Therapy Major Manufacturers Table 8. Cancer & Tumor Therapy Major Manufacturers Table 9. Others Major Manufacturers Table 10. Liposomes Industry Trends Table 11. Liposomes Industry Drivers Table 12. Liposomes Industry Opportunities and Challenges Table 13. Liposomes Industry Restraints Table 14. Global Liposomes Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Liposomes Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Liposomes Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Liposomes Revenue Market Share by Region (2021-2026) Table 18. Global Liposomes Revenue Market Share by Region (2027-2032) Table 19. Global Liposomes Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 20. Global Liposomes Sales by Region (2021-2026) & (W Units) Table 21. Global Liposomes Sales by Region (2027-2032) & (W Units) Table 22. Global Liposomes Sales Market Share by Region (2021-2026) Table 23. Global Liposomes Sales Market Share by Region (2027-2032) Table 24. Global Liposomes Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Liposomes Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Liposomes Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Liposomes Sales Market Share by Manufacturers (2021-2026) Table 28. Global Liposomes Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Liposomes Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Liposomes Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Liposomes Manufacturers, Product Type & Application Table 32. Global Liposomes Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Liposomes by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Liposomes Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Liposomes Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Liposomes Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Liposomes Revenue Market Share by Type (2021-2026) Table 39. Global Liposomes Revenue Market Share by Type (2027-2032) Table 40. Global Liposomes Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 41. Global Liposomes Sales by Type (2021-2026) & (W Units) Table 42. Global Liposomes Sales by Type (2027-2032) & (W Units) Table 43. Global Liposomes Sales Market Share by Type (2021-2026) Table 44. Global Liposomes Sales Market Share by Type (2027-2032) Table 45. Global Liposomes Price by Type (2021-2026) & (US$/Unit) Table 46. Global Liposomes Price by Type (2027-2032) & (US$/Unit) Table 47. Global Liposomes Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Liposomes Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Liposomes Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Liposomes Revenue Market Share by Application (2021-2026) Table 51. Global Liposomes Revenue Market Share by Application (2027-2032) Table 52. Global Liposomes Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 53. Global Liposomes Sales by Application (2021-2026) & (W Units) Table 54. Global Liposomes Sales by Application (2027-2032) & (W Units) Table 55. Global Liposomes Sales Market Share by Application (2021-2026) Table 56. Global Liposomes Sales Market Share by Application (2027-2032) Table 57. Global Liposomes Price by Application (2021-2026) & (US$/Unit) Table 58. Global Liposomes Price by Application (2027-2032) & (US$/Unit) Table 59. CSPC Company Information Table 60. CSPC Business Overview Table 61. CSPC Liposomes Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. CSPC Liposomes Product Portfolio Table 63. CSPC Recent Development Table 64. Fudan-Zhangjiang Company Information Table 65. Fudan-Zhangjiang Business Overview Table 66. Fudan-Zhangjiang Liposomes Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Fudan-Zhangjiang Liposomes Product Portfolio Table 68. Fudan-Zhangjiang Recent Development Table 69. Gilead Sciences Company Information Table 70. Gilead Sciences Business Overview Table 71. Gilead Sciences Liposomes Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Gilead Sciences Liposomes Product Portfolio Table 73. Gilead Sciences Recent Development Table 74. Kingond Pharm Company Information Table 75. Kingond Pharm Business Overview Table 76. Kingond Pharm Liposomes Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Kingond Pharm Liposomes Product Portfolio Table 78. Kingond Pharm Recent Development Table 79. Luye Pharma Company Information Table 80. Luye Pharma Business Overview Table 81. Luye Pharma Liposomes Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Luye Pharma Liposomes Product Portfolio Table 83. Luye Pharma Recent Development Table 84. Pacira Company Information Table 85. Pacira Business Overview Table 86. Pacira Liposomes Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Pacira Liposomes Product Portfolio Table 88. Pacira Recent Development Table 89. Sigma-Tau Group Company Information Table 90. Sigma-Tau Group Business Overview Table 91. Sigma-Tau Group Liposomes Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Sigma-Tau Group Liposomes Product Portfolio Table 93. Sigma-Tau Group Recent Development Table 94. Spectrum Pharmaceuticals Company Information Table 95. Spectrum Pharmaceuticals Business Overview Table 96. Spectrum Pharmaceuticals Liposomes Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Spectrum Pharmaceuticals Liposomes Product Portfolio Table 98. Spectrum Pharmaceuticals Recent Development Table 99. Teva Pharmaceutical Company Information Table 100. Teva Pharmaceutical Business Overview Table 101. Teva Pharmaceutical Liposomes Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Teva Pharmaceutical Liposomes Product Portfolio Table 103. Teva Pharmaceutical Recent Development Table 104. Novartis Company Information Table 105. Novartis Business Overview Table 106. Novartis Liposomes Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Novartis Liposomes Product Portfolio Table 108. Novartis Recent Development Table 109. Johnson & Johnson Company Information Table 110. Johnson & Johnson Business Overview Table 111. Johnson & Johnson Liposomes Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Johnson & Johnson Liposomes Product Portfolio Table 113. Johnson & Johnson Recent Development Table 114. Shanghai New Asia Company Information Table 115. Shanghai New Asia Business Overview Table 116. Shanghai New Asia Liposomes Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Shanghai New Asia Liposomes Product Portfolio Table 118. Shanghai New Asia Recent Development Table 119. Sun Pharmaceutical Company Information Table 120. Sun Pharmaceutical Business Overview Table 121. Sun Pharmaceutical Liposomes Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Sun Pharmaceutical Liposomes Product Portfolio Table 123. Sun Pharmaceutical Recent Development Table 124. North America Liposomes Revenue by Type (2021-2026) & (US$ Million) Table 125. North America Liposomes Revenue by Type (2027-2032) & (US$ Million) Table 126. North America Liposomes Sales by Type (2021-2026) & (W Units) Table 127. North America Liposomes Sales by Type (2027-2032) & (W Units) Table 128. North America Liposomes Sales Price by Type (2021-2026) & (US$/Unit) Table 129. North America Liposomes Sales Price by Type (2027-2032) & (US$/Unit) Table 130. North America Liposomes Revenue by Application (2021-2026) & (US$ Million) Table 131. North America Liposomes Revenue by Application (2027-2032) & (US$ Million) Table 132. North America Liposomes Sales by Application (2021-2026) & (W Units) Table 133. North America Liposomes Sales by Application (2027-2032) & (W Units) Table 134. North America Liposomes Sales Price by Application (2021-2026) & (US$/Unit) Table 135. North America Liposomes Sales Price by Application (2027-2032) & (US$/Unit) Table 136. North America Liposomes Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. North America Liposomes Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. North America Liposomes Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. North America Liposomes Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 140. North America Liposomes Sales by Country (2021-2026) & (W Units) Table 141. North America Liposomes Sales by Country (2027-2032) & (W Units) Table 142. North America Liposomes Sales Price by Country (2021-2026) & (US$/Unit) Table 143. North America Liposomes Sales Price by Country (2027-2032) & (US$/Unit) Table 144. United States Liposomes Revenue (2021-2032) & (US$ Million) Table 145. Canada Liposomes Revenue (2021-2032) & (US$ Million) Table 146. Europe Liposomes Revenue by Type (2021-2026) & (US$ Million) Table 147. Europe Liposomes Revenue by Type (2027-2032) & (US$ Million) Table 148. Europe Liposomes Sales by Type (2021-2026) & (W Units) Table 149. Europe Liposomes Sales by Type (2027-2032) & (W Units) Table 150. Europe Liposomes Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Europe Liposomes Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Europe Liposomes Revenue by Application (2021-2026) & (US$ Million) Table 153. Europe Liposomes Revenue by Application (2027-2032) & (US$ Million) Table 154. Europe Liposomes Sales by Application (2021-2026) & (W Units) Table 155. Europe Liposomes Sales by Application (2027-2032) & (W Units) Table 156. Europe Liposomes Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Europe Liposomes Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Europe Liposomes Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Europe Liposomes Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Europe Liposomes Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Europe Liposomes Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 162. Europe Liposomes Sales by Country (2021-2026) & (W Units) Table 163. Europe Liposomes Sales by Country (2027-2032) & (W Units) Table 164. Europe Liposomes Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Europe Liposomes Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Germany Liposomes Revenue (2021-2032) & (US$ Million) Table 167. France Liposomes Revenue (2021-2032) & (US$ Million) Table 168. U.K. Liposomes Revenue (2021-2032) & (US$ Million) Table 169. Italy Liposomes Revenue (2021-2032) & (US$ Million) Table 170. Netherlands Liposomes Revenue (2021-2032) & (US$ Million) Table 171. China Liposomes Revenue by Type (2021-2026) & (US$ Million) Table 172. China Liposomes Revenue by Type (2027-2032) & (US$ Million) Table 173. China Liposomes Sales by Type (2021-2026) & (W Units) Table 174. China Liposomes Sales by Type (2027-2032) & (W Units) Table 175. China Liposomes Sales Price by Type (2021-2026) & (US$/Unit) Table 176. China Liposomes Sales Price by Type (2027-2032) & (US$/Unit) Table 177. China Liposomes Revenue by Application (2021-2026) & (US$ Million) Table 178. China Liposomes Revenue by Application (2027-2032) & (US$ Million) Table 179. China Liposomes Sales by Application (2021-2026) & (W Units) Table 180. China Liposomes Sales by Application (2027-2032) & (W Units) Table 181. China Liposomes Sales Price by Application (2021-2026) & (US$/Unit) Table 182. China Liposomes Sales Price by Application (2027-2032) & (US$/Unit) Table 183. Asia Liposomes Revenue by Type (2021-2026) & (US$ Million) Table 184. Asia Liposomes Revenue by Type (2027-2032) & (US$ Million) Table 185. Asia Liposomes Sales by Type (2021-2026) & (W Units) Table 186. Asia Liposomes Sales by Type (2027-2032) & (W Units) Table 187. Asia Liposomes Sales Price by Type (2021-2026) & (US$/Unit) Table 188. Asia Liposomes Sales Price by Type (2027-2032) & (US$/Unit) Table 189. Asia Liposomes Revenue by Application (2021-2026) & (US$ Million) Table 190. Asia Liposomes Revenue by Application (2027-2032) & (US$ Million) Table 191. Asia Liposomes Sales by Application (2021-2026) & (W Units) Table 192. Asia Liposomes Sales by Application (2027-2032) & (W Units) Table 193. Asia Liposomes Sales Price by Application (2021-2026) & (US$/Unit) Table 194. Asia Liposomes Sales Price by Application (2027-2032) & (US$/Unit) Table 195. Asia Liposomes Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. Asia Liposomes Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. Asia Liposomes Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. Asia Liposomes Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 199. Asia Liposomes Sales by Country (2021-2026) & (W Units) Table 200. Asia Liposomes Sales by Country (2027-2032) & (W Units) Table 201. Asia Liposomes Sales Price by Country (2021-2026) & (US$/Unit) Table 202. Asia Liposomes Sales Price by Country (2027-2032) & (US$/Unit) Table 203. Japan Liposomes Revenue (2021-2032) & (US$ Million) Table 204. South Korea Liposomes Revenue (2021-2032) & (US$ Million) Table 205. India Liposomes Revenue (2021-2032) & (US$ Million) Table 206. Australia Liposomes Revenue (2021-2032) & (US$ Million) Table 207. China Taiwan Liposomes Revenue (2021-2032) & (US$ Million) Table 208. Southeast Asia Liposomes Revenue (2021-2032) & (US$ Million) Table 209. SAMEA Liposomes Revenue by Type (2021-2026) & (US$ Million) Table 210. SAMEA Liposomes Revenue by Type (2027-2032) & (US$ Million) Table 211. SAMEA Liposomes Sales by Type (2021-2026) & (W Units) Table 212. SAMEA Liposomes Sales by Type (2027-2032) & (W Units) Table 213. SAMEA Liposomes Sales Price by Type (2021-2026) & (US$/Unit) Table 214. SAMEA Liposomes Sales Price by Type (2027-2032) & (US$/Unit) Table 215. SAMEA Liposomes Revenue by Application (2021-2026) & (US$ Million) Table 216. SAMEA Liposomes Revenue by Application (2027-2032) & (US$ Million) Table 217. SAMEA Liposomes Sales by Application (2021-2026) & (W Units) Table 218. SAMEA Liposomes Sales by Application (2027-2032) & (W Units) Table 219. SAMEA Liposomes Sales Price by Application (2021-2026) & (US$/Unit) Table 220. SAMEA Liposomes Sales Price by Application (2027-2032) & (US$/Unit) Table 221. SAMEA Liposomes Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. SAMEA Liposomes Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 223. SAMEA Liposomes Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 224. SAMEA Liposomes Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 225. SAMEA Liposomes Sales by Country (2021-2026) & (W Units) Table 226. SAMEA Liposomes Sales by Country (2027-2032) & (W Units) Table 227. SAMEA Liposomes Sales Price by Country (2021-2026) & (US$/Unit) Table 228. SAMEA Liposomes Sales Price by Country (2027-2032) & (US$/Unit) Table 229. Brazil Liposomes Revenue (2021-2032) & (US$ Million) Table 230. Argentina Liposomes Revenue (2021-2032) & (US$ Million) Table 231. Chile Liposomes Revenue (2021-2032) & (US$ Million) Table 232. Colombia Liposomes Revenue (2021-2032) & (US$ Million) Table 233. Peru Liposomes Revenue (2021-2032) & (US$ Million) Table 234. Saudi Arabia Liposomes Revenue (2021-2032) & (US$ Million) Table 235. Israel Liposomes Revenue (2021-2032) & (US$ Million) Table 236. UAE Liposomes Revenue (2021-2032) & (US$ Million) Table 237. Turkey Liposomes Revenue (2021-2032) & (US$ Million) Table 238. Iran Liposomes Revenue (2021-2032) & (US$ Million) Table 239. Egypt Liposomes Revenue (2021-2032) & (US$ Million) Table 240. Key Raw Materials Table 241. Raw Materials Key Suppliers Table 242. Liposomes Distributors List Table 243. Liposomes Customers List Table 244. Research Programs/Design for This Report Table 245. Authors List of This Report Table 246. Secondary Sources Table 247. Primary Sources List of Figures Figure 1. Liposomes Image Figure 2. Global Liposomes Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liposomes Market Size Share 2021 VS 2025 VS 2032 Figure 4. Liposomal Doxorubicin Image Figure 5. Liposomal Amphoteracin B Image Figure 6. Liposomal Paclitaxel Image Figure 7. Others Image Figure 8. Global Liposomes Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Liposomes Market Size Share 2021 VS 2025 VS 2032 Figure 10. Fungal Infection Therapy Image Figure 11. Cancer & Tumor Therapy Image Figure 12. Others Image Figure 13. Global Liposomes Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Liposomes Revenue (2021-2032) & (US$ Million) Figure 15. Global Liposomes Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Liposomes Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Liposomes Revenue Market Share by Region (2021-2032) Figure 18. Global Liposomes Sales (2021-2032) & (W Units) Figure 19. Global Liposomes Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 20. Global Liposomes Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Liposomes Sales YoY (2021-2032) & (W Units) Figure 22. Europe Liposomes Sales YoY (2021-2032) & (W Units) Figure 23. China Liposomes Sales YoY (2021-2032) & (W Units) Figure 24. Asia (Excluding China) Liposomes Sales YoY (2021-2032) & (W Units) Figure 25. South America, Middle East and Africa Liposomes Sales YoY (2021-2032) & (W Units) Figure 26. Global Liposomes Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Liposomes Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Liposomes Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Liposomes Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Liposomes Revenue Market Share by Type (2021-2032) Figure 32. Global Liposomes Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 33. Global Liposomes Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Liposomes Sales Market Share by Type (2021-2032) Figure 35. Global Liposomes Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Liposomes Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Liposomes Revenue Market Share by Application (2021-2032) Figure 38. Global Liposomes Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 39. Global Liposomes Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Liposomes Sales Market Share by Application (2021-2032) Figure 41. North America Liposomes Revenue Share by Type (2021-2032) Figure 42. North America Liposomes Sales Share by Type (2021-2032) Figure 43. North America Liposomes Revenue Share by Application (2021-2032) Figure 44. North America Liposomes Sales Share by Application (2021-2032) Figure 45. North America Liposomes Revenue Share by Country (2021-2032) Figure 46. North America Liposomes Sales Share by Country (2021-2032) Figure 47. Europe Liposomes Revenue Share by Type (2021-2032) Figure 48. Europe Liposomes Sales Share by Type (2021-2032) Figure 49. Europe Liposomes Revenue Share by Application (2021-2032) Figure 50. Europe Liposomes Sales Share by Application (2021-2032) Figure 51. Europe Liposomes Revenue Share by Country (2021-2032) Figure 52. Europe Liposomes Sales Share by Country (2021-2032) Figure 53. China Liposomes Revenue Share by Type (2021-2032) Figure 54. China Liposomes Sales Share by Type (2021-2032) Figure 55. China Liposomes Revenue Share by Application (2021-2032) Figure 56. China Liposomes Sales Share by Application (2021-2032) Figure 57. Asia Liposomes Revenue Share by Type (2021-2032) Figure 58. Asia Liposomes Sales Share by Type (2021-2032) Figure 59. Asia Liposomes Revenue Share by Application (2021-2032) Figure 60. Asia Liposomes Sales Share by Application (2021-2032) Figure 61. Asia Liposomes Revenue Share by Country (2021-2032) Figure 62. Asia Liposomes Sales Share by Country (2021-2032) Figure 63. SAMEA Liposomes Revenue Share by Type (2021-2032) Figure 64. SAMEA Liposomes Sales Share by Type (2021-2032) Figure 65. SAMEA Liposomes Revenue Share by Application (2021-2032) Figure 66. SAMEA Liposomes Sales Share by Application (2021-2032) Figure 67. SAMEA Liposomes Revenue Share by Country (2021-2032) Figure 68. SAMEA Liposomes Sales Share by Country (2021-2032) Figure 69. Liposomes Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Liposomes Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Liposomal Doxorubicin
  • Liposomal Amphoteracin B
  • Liposomal Paclitaxel
  • Others
Applications
  • Fungal Infection Therapy
  • Cancer & Tumor Therapy
  • Others
Companies covered
  • CSPC
  • Fudan-Zhangjiang
  • Gilead Sciences
  • Kingond Pharm
  • Luye Pharma
  • Pacira
  • Sigma-Tau Group
  • Spectrum Pharmaceuticals
  • Teva Pharmaceutical
  • Novartis
  • Johnson & Johnson
  • Shanghai New Asia
  • Sun Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Liposomes Market by Type
  3. 1.2.1 Global Liposomes Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Liposomal Doxorubicin
  5. 1.2.3 Liposomal Amphoteracin B
  6. 1.2.4 Liposomal Paclitaxel
  7. 1.2.5 Others
  8. 1.3 Liposomes Market by Application
  9. 1.3.1 Global Liposomes Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Fungal Infection Therapy
  11. 1.3.3 Cancer & Tumor Therapy
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Liposomes Market Dynamics
  1. 2.1 Liposomes Industry Trends
  2. 2.2 Liposomes Industry Drivers
  3. 2.3 Liposomes Industry Opportunities and Challenges
  4. 2.4 Liposomes Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Liposomes Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Liposomes Revenue by Region
  3. 3.2.1 Global Liposomes Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Liposomes Revenue by Region (2021-2026)
  5. 3.2.3 Global Liposomes Revenue by Region (2027-2032)
  6. 3.2.4 Global Liposomes Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Liposomes Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Liposomes Sales by Region
  9. 3.4.1 Global Liposomes Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Liposomes Sales by Region (2021-2026)
  11. 3.4.3 Global Liposomes Sales by Region (2027-2032)
  12. 3.4.4 Global Liposomes Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Liposomes Revenue by Manufacturers
  2. 4.1.1 Global Liposomes Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Liposomes Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Liposomes Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Liposomes Sales by Manufacturers
  6. 4.2.1 Global Liposomes Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Liposomes Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Liposomes Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Liposomes Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Liposomes Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Liposomes Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Liposomes Manufacturers, Product Type & Application
  13. 4.7 Global Liposomes Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Liposomes Market CR5 and HHI
  16. 4.8.2 2025 Liposomes Tier 1, Tier 2, and Tier 3
5 Liposomes Market by Type
  1. 5.1 Global Liposomes Revenue by Type
  2. 5.1.1 Global Liposomes Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Liposomes Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Liposomes Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Liposomes Sales by Type
  6. 5.2.1 Global Liposomes Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Liposomes Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Liposomes Sales Market Share by Type (2021-2032)
  9. 5.3 Global Liposomes Price by Type
6 Liposomes Market by Application
  1. 6.1 Global Liposomes Revenue by Application
  2. 6.1.1 Global Liposomes Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Liposomes Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Liposomes Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Liposomes Sales by Application
  6. 6.2.1 Global Liposomes Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Liposomes Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Liposomes Sales Market Share by Application (2021-2032)
  9. 6.3 Global Liposomes Price by Application
7 Company Profiles
  1. 7.1 CSPC
  2. 7.1.1 CSPC Company Information
  3. 7.1.2 CSPC Business Overview
  4. 7.1.3 CSPC Liposomes Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CSPC Liposomes Product Portfolio
  6. 7.1.5 CSPC Recent Developments
  7. 7.2 Fudan-Zhangjiang
  8. 7.2.1 Fudan-Zhangjiang Company Information
  9. 7.2.2 Fudan-Zhangjiang Business Overview
  10. 7.2.3 Fudan-Zhangjiang Liposomes Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Fudan-Zhangjiang Liposomes Product Portfolio
  12. 7.2.5 Fudan-Zhangjiang Recent Developments
  13. 7.3 Gilead Sciences
  14. 7.3.1 Gilead Sciences Company Information
  15. 7.3.2 Gilead Sciences Business Overview
  16. 7.3.3 Gilead Sciences Liposomes Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Gilead Sciences Liposomes Product Portfolio
  18. 7.3.5 Gilead Sciences Recent Developments
  19. 7.4 Kingond Pharm
  20. 7.4.1 Kingond Pharm Company Information
  21. 7.4.2 Kingond Pharm Business Overview
  22. 7.4.3 Kingond Pharm Liposomes Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Kingond Pharm Liposomes Product Portfolio
  24. 7.4.5 Kingond Pharm Recent Developments
  25. 7.5 Luye Pharma
  26. 7.5.1 Luye Pharma Company Information
  27. 7.5.2 Luye Pharma Business Overview
  28. 7.5.3 Luye Pharma Liposomes Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Luye Pharma Liposomes Product Portfolio
  30. 7.5.5 Luye Pharma Recent Developments
  31. 7.6 Pacira
  32. 7.6.1 Pacira Company Information
  33. 7.6.2 Pacira Business Overview
  34. 7.6.3 Pacira Liposomes Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pacira Liposomes Product Portfolio
  36. 7.6.5 Pacira Recent Developments
  37. 7.7 Sigma-Tau Group
  38. 7.7.1 Sigma-Tau Group Company Information
  39. 7.7.2 Sigma-Tau Group Business Overview
  40. 7.7.3 Sigma-Tau Group Liposomes Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Sigma-Tau Group Liposomes Product Portfolio
  42. 7.7.5 Sigma-Tau Group Recent Developments
  43. 7.8 Spectrum Pharmaceuticals
  44. 7.8.1 Spectrum Pharmaceuticals Company Information
  45. 7.8.2 Spectrum Pharmaceuticals Business Overview
  46. 7.8.3 Spectrum Pharmaceuticals Liposomes Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Spectrum Pharmaceuticals Liposomes Product Portfolio
  48. 7.8.5 Spectrum Pharmaceuticals Recent Developments
  49. 7.9 Teva Pharmaceutical
  50. 7.9.1 Teva Pharmaceutical Company Information
  51. 7.9.2 Teva Pharmaceutical Business Overview
  52. 7.9.3 Teva Pharmaceutical Liposomes Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Teva Pharmaceutical Liposomes Product Portfolio
  54. 7.9.5 Teva Pharmaceutical Recent Developments
  55. 7.10 Novartis
  56. 7.10.1 Novartis Company Information
  57. 7.10.2 Novartis Business Overview
  58. 7.10.3 Novartis Liposomes Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Novartis Liposomes Product Portfolio
  60. 7.10.5 Novartis Recent Developments
  61. 7.11 Johnson & Johnson
  62. 7.11.1 Johnson & Johnson Company Information
  63. 7.11.2 Johnson & Johnson Business Overview
  64. 7.11.3 Johnson & Johnson Liposomes Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Johnson & Johnson Liposomes Product Portfolio
  66. 7.11.5 Johnson & Johnson Recent Developments
  67. 7.12 Shanghai New Asia
  68. 7.12.1 Shanghai New Asia Company Information
  69. 7.12.2 Shanghai New Asia Business Overview
  70. 7.12.3 Shanghai New Asia Liposomes Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Shanghai New Asia Liposomes Product Portfolio
  72. 7.12.5 Shanghai New Asia Recent Developments
  73. 7.13 Sun Pharmaceutical
  74. 7.13.1 Sun Pharmaceutical Company Information
  75. 7.13.2 Sun Pharmaceutical Business Overview
  76. 7.13.3 Sun Pharmaceutical Liposomes Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Sun Pharmaceutical Liposomes Product Portfolio
  78. 7.13.5 Sun Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Liposomes Market Size by Type
  2. 8.1.1 North America Liposomes Revenue by Type (2021-2032)
  3. 8.1.2 North America Liposomes Sales by Type (2021-2032)
  4. 8.1.3 North America Liposomes Price by Type (2021-2032)
  5. 8.2 North America Liposomes Market Size by Application
  6. 8.2.1 North America Liposomes Revenue by Application (2021-2032)
  7. 8.2.2 North America Liposomes Sales by Application (2021-2032)
  8. 8.2.3 North America Liposomes Price by Application (2021-2032)
  9. 8.3 North America Liposomes Market Size by Country
  10. 8.3.1 North America Liposomes Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Liposomes Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Liposomes Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Liposomes Market Size by Type
  2. 9.1.1 Europe Liposomes Revenue by Type (2021-2032)
  3. 9.1.2 Europe Liposomes Sales by Type (2021-2032)
  4. 9.1.3 Europe Liposomes Price by Type (2021-2032)
  5. 9.2 Europe Liposomes Market Size by Application
  6. 9.2.1 Europe Liposomes Revenue by Application (2021-2032)
  7. 9.2.2 Europe Liposomes Sales by Application (2021-2032)
  8. 9.2.3 Europe Liposomes Price by Application (2021-2032)
  9. 9.3 Europe Liposomes Market Size by Country
  10. 9.3.1 Europe Liposomes Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Liposomes Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Liposomes Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Liposomes Market Size by Type
  2. 10.1.1 China Liposomes Revenue by Type (2021-2032)
  3. 10.1.2 China Liposomes Sales by Type (2021-2032)
  4. 10.1.3 China Liposomes Price by Type (2021-2032)
  5. 10.2 China Liposomes Market Size by Application
  6. 10.2.1 China Liposomes Revenue by Application (2021-2032)
  7. 10.2.2 China Liposomes Sales by Application (2021-2032)
  8. 10.2.3 China Liposomes Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Liposomes Market Size by Type
  2. 11.1.1 Asia Liposomes Revenue by Type (2021-2032)
  3. 11.1.2 Asia Liposomes Sales by Type (2021-2032)
  4. 11.1.3 Asia Liposomes Price by Type (2021-2032)
  5. 11.2 Asia Liposomes Market Size by Application
  6. 11.2.1 Asia Liposomes Revenue by Application (2021-2032)
  7. 11.2.2 Asia Liposomes Sales by Application (2021-2032)
  8. 11.2.3 Asia Liposomes Price by Application (2021-2032)
  9. 11.3 Asia Liposomes Market Size by Country
  10. 11.3.1 Asia Liposomes Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Liposomes Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Liposomes Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Liposomes Market Size by Type
  2. 12.1.1 SAMEA Liposomes Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Liposomes Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Liposomes Price by Type (2021-2032)
  5. 12.2 SAMEA Liposomes Market Size by Application
  6. 12.2.1 SAMEA Liposomes Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Liposomes Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Liposomes Price by Application (2021-2032)
  9. 12.3 SAMEA Liposomes Market Size by Country
  10. 12.3.1 SAMEA Liposomes Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Liposomes Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Liposomes Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Liposomes Value Chain Analysis
  2. 13.1.1 Liposomes Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Liposomes Production Mode & Process
  6. 13.2 Liposomes Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Liposomes Distributors
  9. 13.2.3 Liposomes Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst